Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials_resource:3dd9edb0933bb9cf72794bf515e224dc]
Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00144859]Advair® DISKUS® (Fluticasone Propionate/Salmeterol) Versus Serevent® DISKUS® (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations [clinicaltrials:NCT00144911]GR Defect in Sputum Cells in COPD [clinicaltrials:NCT00159276]Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00164138]Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT) [clinicaltrials:NCT00181285]Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00202176]Evaluating Genes in Sputum to Measure Drug Response in COPD [clinicaltrials:NCT00233051]Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06) [clinicaltrials:NCT00242294]Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08) [clinicaltrials:NCT00246935]Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00259909]Sodium Pyruvate Therapy in COPD Patients [clinicaltrials:NCT00262613]Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00279019]Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00288548]Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD [clinicaltrials:NCT00291408]Relative Potency of Inhaled Corticosteroids [clinicaltrials:NCT00292838]clinicaltrials:NCT00297102clinicaltrials:NCT00297115clinicaltrials:NCT00313209SERETIDE Plus Tiotropium Versus Individual Components [clinicaltrials:NCT00325169]ADVAIR DISKUS (Fluticasone Propionate/Salmeterol) Versus SEREVENT DISKUS (Salmeterol) On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00346749]Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00355342]Chronic Obstructive Pulmonary Disease Endpoints Study [clinicaltrials:NCT00358358]clinicaltrials:NCT00358436clinicaltrials:NCT00363896GSK159802 In Healthy Male Subjects And Asthmatics [clinicaltrials:NCT00364273]Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00376714]Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00379730]clinicaltrials:NCT00383435clinicaltrials:NCT00383721clinicaltrials:NCT00387036A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease) [clinicaltrials:NCT00392587]A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED) [clinicaltrials:NCT00418613]Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00422604]Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients [clinicaltrials:NCT00435760]The Effect of Neuromuscular Electrical Stimulation [clinicaltrials:NCT00442728]A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B. [clinicaltrials:NCT00453479]Dyspnea Self-Management: Internet or Face-to-Face [clinicaltrials:NCT00461162]An Intervention to Improve Function in Severe Cardiopulmonary Illness [clinicaltrials:NCT00467298]A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers [clinicaltrials:NCT00475436]Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705 [clinicaltrials:NCT00500461]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials_resource:3dd9edb0933bb9cf72794bf515e224dc]
Bio2RDF identifier
3dd9edb0933bb9cf72794bf515e224dc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3dd9edb0933bb9cf72794bf515e224dc
identifier
clinicaltrials_resource:3dd9edb0933bb9cf72794bf515e224dc
title
Chronic Obstructive Pulmonary Disease (COPD)
@en
type
label
Chronic Obstructive Pulmonary ...... 9edb0933bb9cf72794bf515e224dc]
@en